Sarepta Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $2.41B | $3.26B | $428.4M |
| FY2024 | $2.44B | $3.96B | $1.10B |
| FY2025 | $2.21B | $3.35B | $801.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $2.41B | $3.26B | $428.4M |
| FY2024 | $2.44B | $3.96B | $1.10B |
| FY2025 | $2.21B | $3.35B | $801.3M |